Spire Wealth Management’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-24,117
Closed -$184K 2789
2022
Q1
$184K Buy
24,117
+12,484
+107% +$96.6K ﹤0.01% 931
2021
Q4
$107K Buy
11,633
+300
+3% +$3.19K ﹤0.01% 1376
2021
Q3
$161K Buy
+11,333
New +$176K ﹤0.01% 1004

Other funds holding ORGO

Spire Wealth Management's ORGO Position: Q2 2022 in Review

Spire Wealth Management sold out of Organogenesis Holdings (ORGO) in Q2 2022, closing a stake of 24,117 shares — an estimated $184K sold.

Spire Wealth Management first reported a position in ORGO in Q3 2021 and held it in 3 quarters. The position peaked at $184K in Q1 2022. 146 funds tracked by Wall St. Rank hold ORGO as of Q2 2022.

  • Spire Wealth Management reported no remaining Organogenesis Holdings position as of Q2 2022 after selling out during the quarter.
  • Spire Wealth Management sold 24,117 Organogenesis Holdings shares in Q2 2022, an estimated $184K.
  • Spire Wealth Management first reported a position in Organogenesis Holdings in Q3 2021 and held it in 3 quarters.
  • Spire Wealth Management's Organogenesis Holdings position peaked at $184K in Q1 2022.
  • 146 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2022.

Based on Spire Wealth Management's 13F filing for Q2 2022, filed 22 Jul 2022.